Case File №
#VI-2026-0308
Shandong Aishi Biotechnology
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
36 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Tirzepatide | D Poor | 21 | 7.0 | 3.2 | 10.0 | 6 Oct 2025 |
| Retatrutide | E Bad | 16 | 7.0 | 0.8 | 10.0 | 24 Oct 2025 |
| 17a-Methyl-1-Testosterone | X N/A | 1 | 5.5 | 5.5 | 5.5 | 3 Jul 2025 |
| AA Water | X N/A | 2 | 6.1 | 5.4 | 6.8 | 26 Jan 2026 |
| Andarine S4 | X N/A | 1 | 8.4 | 8.4 | 8.4 | 28 Mar 2025 |
| AOD9604 | X N/A | 2 | 6.2 | 6.0 | 6.3 | 25 May 2026 |
| Aromasin (Exemestane) | X N/A | 1 | 6.2 | 6.2 | 6.2 | 3 Jun 2025 |
| Blend 500 (Tren E/Mast E) | X N/A | 2 | 5.5 | 2.9 | 8.2 | 21 May 2026 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 3 | 6.4 | 3.9 | 9.3 | 26 Jan 2026 |
| Cartalax | X N/A | 3 | 5.3 | 4.5 | 6.5 | 19 Jan 2026 |
| Chonluten | X N/A | 2 | 6.0 | 5.1 | 6.9 | 21 May 2026 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 1 | 5.0 | 5.0 | 5.0 | 2 Jul 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 2 | 5.8 | 5.6 | 5.9 | 26 Jan 2026 |
| DHT (Stanolone) | X N/A | 3 | 6.2 | 3.5 | 8.0 | 24 May 2026 |
| Dianabol Oil | X N/A | 3 | 5.8 | 4.7 | 7.5 | 20 May 2026 |
| Dianabol | X N/A | 3 | 7.8 | 6.7 | 8.6 | 20 May 2026 |
| Epithalon | X N/A | 2 | 6.8 | 6.6 | 7.0 | 24 May 2026 |
| EPO | X N/A | 2 | 7.6 | 7.1 | 8.2 | 21 May 2026 |
| GHRP-2 Acetate | X N/A | 2 | 8.3 | 7.2 | 9.4 | 19 Jan 2026 |
| Hyaluronic acid | X N/A | 2 | 8.3 | 8.3 | 8.3 | 17 May 2026 |
| Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) | X N/A | 1 | 6.7 | 6.7 | 6.7 | 27 Feb 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 7.3 | 7.3 | 7.3 | 24 Apr 2025 |
| Liraglutide | X N/A | 1 | 7.6 | 7.6 | 7.6 | 3 Jun 2025 |
| Masteron P (Drostanolone P) | X N/A | 3 | 7.2 | 5.7 | 9.4 | 23 May 2026 |
| Orforglipron | X N/A | 3 | 7.7 | 7.2 | 8.5 | 26 Jan 2026 |
| P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | X N/A | 1 | 9.0 | 9.0 | 9.0 | 7 May 2025 |
| Pancragen | X N/A | 3 | 6.0 | 4.7 | 6.7 | 24 May 2026 |
| PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | X N/A | 1 | 8.2 | 8.2 | 8.2 | 7 May 2025 |
| Salbutamol | X N/A | 3 | 8.0 | 6.4 | 10.0 | 19 Jan 2026 |
| Super Shred | X N/A | 3 | 6.9 | 6.2 | 7.6 | 25 May 2026 |
| Sustanon 400 | X N/A | 2 | 6.5 | 4.6 | 8.3 | 26 Jan 2026 |
| Teriparatide | X N/A | 3 | 8.1 | 6.1 | 9.5 | 20 May 2026 |
| Testagen | X N/A | 3 | 6.8 | 5.3 | 7.7 | 17 May 2026 |
| Tren Hex | X N/A | 3 | 8.0 | 6.6 | 9.3 | 24 May 2026 |
| Vitamin B12 10mg/ml | X N/A | 3 | 7.8 | 5.7 | 9.1 | 25 May 2026 |
| YK11 | X N/A | 1 | 8.1 | 8.1 | 8.1 | 14 Jan 2025 |
Exhibit II
Evidence Log
79 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | DHT (Stanolone) | 6.4 A | 300mg/ml | 259.4mg/ml | -13.5% | 98.71% | e48u2e | Lab C | Public |
| 24 May 2026 | Chonluten | 6.7 A | 10mg | 10.3mg | +3.2% | 98.34% | b1jj3t | Lab B | Community |
| 24 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 6.5 A | 10mg | 12.2mg | +21.6% | 97.03% | e21ecg | Lab F | Public |
| 24 May 2026 | Pancragen | 5.6 B | 30mg | 34.6mg | +15.3% | 95.38% | 63n8nr | Lab E | Public |
| 24 May 2026 | Tren Hex | 5.9 B | 250mg/ml | 311.5mg/ml | +24.6% | 95.48% | bswyrg | Lab C | Public |
| 24 May 2026 | AA Water | 4.9 C | 15mg | 16.0mg | +6.6% | 95.14% | ewyitb | Lab D | Public |
| 24 May 2026 | AA Water | 6.2 A | 10mg | 9.2mg | -7.9% | 99.53% | su1cii | Lab A | Public |
| 24 May 2026 | AOD9604 | 6.1 A | 10mg | 9.1mg | -9.0% | 99.95% | obamtt | Lab G | Community |
| 24 May 2026 | Cartalax | 5.6 B | 15mg | 18.3mg | +22.0% | 96.59% | becc9x | Lab E | Public |
| 24 May 2026 | Dianabol Oil | 4.0 C | 250mg/ml | 261.3mg/ml | +4.5% | 96.63% | fwca5t | Lab G | Community |
| 24 May 2026 | Hyaluronic acid | 7.4 A | 2mg | 2.0mg | +1.2% | 97.98% | v3zqcf | Lab G | Community |
| 24 May 2026 | Tren Hex | 7.3 A | 250mg/ml | 244.5mg/ml | -2.2% | 99.89% | 4n2j1m | Lab D | Public |
| 24 May 2026 | Dianabol Oil | 4.0 C | 100mg/ml | 109.2mg/ml | +9.2% | 95.82% | sd4cgw | Lab G | Community |
| 24 May 2026 | Dianabol Oil | 4.0 C | 200mg/ml | 189.8mg/ml | -5.1% | 95.13% | rzy8hj | Lab D | Community |
| 24 May 2026 | Dianabol | 8.4 A | 25mg | 25.0mg | +0.2% | 97.06% | 7uwroz | Lab D | Public |
| 24 May 2026 | Vitamin B12 10mg/ml | 9.0 A | 200mg/ml | 244.9mg/ml | +22.4% | 95.09% | 9w4qi9 | Lab C | Public |
| 24 May 2026 | Retatrutide | 9.5 A | 10mg | 9.8mg | -2.0% | 99.70% | Yellow Cap | Lab G | Public |
| 24 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 7.9 A | 2mg | 1.7mg | -14.5% | 96.79% | tebpne | Lab B | Public |
| 23 May 2026 | Tirzepatide | 6.0 B | 30mg | 33.5mg | +11.7% | 99.88% | (no batch ID) | Lab E | Public |
| 23 May 2026 | BPC157 5mg + TB500 5mg Blend | 8.0 A | 50mg | 61.7mg | +23.4% | 95.04% | okc6cx | Lab C | Public |
| 23 May 2026 | Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) | 6.4 A | 300mg/ml | 321.1mg/ml | +7.0% | 96.46% | ss8bqa | Lab C | Public |
| 23 May 2026 | Orforglipron | 8.0 A | 100mg | 124.1mg | +24.1% | 98.64% | t2i2v7 | Lab D | Community |
| 23 May 2026 | Super Shred | 6.4 A | 250mg/ml | 280.5mg/ml | +12.2% | 99.58% | 1ab42b | Lab D | Public |
| 23 May 2026 | Blend 500 (Tren E/Mast E) | 4.3 C | 100mg/ml | 92.4mg/ml | -7.6% | 96.30% | yrxowx | Lab E | Community |
| 23 May 2026 | BPC157 5mg + TB500 5mg Blend | 4.7 C | 15mg | 15.3mg | +2.1% | 98.86% | b1y1sr | Lab E | Public |
| 23 May 2026 | Chonluten | 5.9 B | 20mg | 19.8mg | -1.2% | 99.38% | yy1al8 | Lab G | Public |
| 23 May 2026 | PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 | 7.7 A | 5g | 6.2g | +23.1% | 99.11% | xg7w2j | Lab C | Public |
| 22 May 2026 | Retatrutide | 10.0 A | 20mg | 20.6mg | +3.0% | 99.90% | 11Sept25-SS64 | Lab E | Public |
| 21 May 2026 | Tirzepatide | 8.8 A | 50mg | 46.2mg | -7.6% | 99.78% | 11Sept25-SS-63 | Lab E | Public |
| 21 May 2026 | Tirzepatide | 5.9 C | 20mg | 22.6mg | +13.0% | 99.90% | (no batch ID) | Lab G | Public |
| 21 May 2026 | Tirzepatide | 6.6 B | 10mg | 15.6mg | +56.0% | 99.90% | T10 | Lab E | Public |
| 21 May 2026 | Tirzepatide | 10.0 A | 5mg | 5.2mg | +4.0% | 99.90% | TR5SD202601 | Lab E | Public |
| 20 May 2026 | Masteron P (Drostanolone P) | 5.4 B | 100mg/ml | 88.5mg/ml | -11.5% | 95.93% | ojtjnu | Lab A | Public |
| 20 May 2026 | Salbutamol | 7.4 A | 50mg | 61.1mg | +22.2% | 97.91% | unls5d | Lab D | Public |
| 20 May 2026 | Testagen | 6.4 A | 30mg | 31.2mg | +4.0% | 97.72% | zjyma6 | Lab E | Community |
| 20 May 2026 | Vitamin B12 10mg/ml | 7.0 A | 300mg/ml | 302.4mg/ml | +0.8% | 99.45% | quagim | Lab A | Public |
| 19 May 2026 | BPC157 5mg + TB500 5mg Blend | 5.6 B | 15mg | 12.9mg | -14.0% | 97.78% | n5bqhh | Lab E | Public |
| 19 May 2026 | GHRP-2 Acetate | 8.9 A | 50mg | 48.1mg | -3.8% | 96.18% | siqspc | Lab C | Public |
| 17 May 2026 | 17a-Methyl-1-Testosterone | 4.8 C | 10mg | 11.7mg | +17.5% | 95.52% | lcb17q | Lab A | Public |
| 17 May 2026 | Cartalax | 7.0 A | 50mg | 51.6mg | +3.1% | 96.48% | 25aocy | Lab C | Community |
| 29 Jan 2026 | Cartalax | 6.2 A | 10mg | 11.5mg | +14.6% | 96.26% | azu3m7 | Lab C | Public |
| 29 Jan 2026 | EPO | 8.5 A | 30mg | 30.0mg | -0.1% | 97.81% | nwqzng | Lab B | Community |
| 29 Jan 2026 | Masteron P (Drostanolone P) | 6.4 A | 250mg/ml | 230.3mg/ml | -7.9% | 99.74% | er68ux | Lab D | Community |
| 29 Jan 2026 | Teriparatide | 7.6 A | 15mg | 18.6mg | +23.8% | 98.53% | df9xwx | Lab A | Public |
| 29 Jan 2026 | Teriparatide | 7.6 A | 20mg | 22.3mg | +11.6% | 97.43% | c80jtu | Lab B | Public |
| 26 Jan 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 4.1 C | 50mg | 52.1mg | +4.2% | 95.39% | c2u7zm | Lab G | Public |
| 26 Jan 2026 | GHRP-2 Acetate | 8.4 A | 10mg | 9.5mg | -5.5% | 96.42% | krjjwp | Lab C | Public |
| 26 Jan 2026 | YK11 | 9.5 A | 25mg | 27.7mg | +10.8% | 97.03% | jzzmge | Lab F | Community |
| 19 Jan 2026 | Epithalon | 8.0 A | 2mg | 2.3mg | +14.2% | 99.96% | g5vg8k | Lab D | Public |
| 9 Jan 2026 | Liraglutide | 6.2 A | 30mg | 33.3mg | +11.0% | 95.06% | ntlm25 | Lab E | Public |
| 9 Jan 2026 | P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | 7.8 A | 500g | 609.2g | +21.8% | 95.78% | witxj9 | Lab E | Community |
| 9 Jan 2026 | Sustanon 400 | 4.0 C | 100mg/ml | 95.5mg/ml | -4.5% | 95.75% | hojpl8 | Lab A | Public |
| 7 Jan 2026 | Blend 500 (Tren E/Mast E) | 6.1 A | 250mg/ml | 250.5mg/ml | +0.2% | 97.74% | n2say8 | Lab C | Public |
| 7 Jan 2026 | Orforglipron | 6.8 A | 50mg | 48.8mg | -2.5% | 98.08% | imur35 | Lab C | Community |
| 7 Jan 2026 | Super Shred | 7.0 A | 250mg/ml | 298.0mg/ml | +19.2% | 97.86% | n6uoy1 | Lab G | Public |
| 6 Jan 2026 | Sustanon 400 | 5.3 B | 200mg/ml | 190.7mg/ml | -4.6% | 96.95% | lxe23v | Lab B | Community |
| 29 Dec 2025 | DHT (Stanolone) | 6.0 A | 100mg/ml | 94.8mg/ml | -5.2% | 97.45% | aio4dh | Lab F | Public |
| 29 Dec 2025 | Masteron P (Drostanolone P) | 7.4 A | 300mg/ml | 325.4mg/ml | +8.5% | 99.21% | gijeij | Lab E | Public |
| 29 Dec 2025 | Teriparatide | 8.0 A | 30mg | 29.7mg | -1.0% | 95.43% | 6xmhd0 | Lab B | Public |
| 12 Dec 2025 | Andarine S4 | 8.4 A | 20mg | 23.7mg | +18.7% | 95.60% | j3ws53 | Lab E | Public |
| 12 Dec 2025 | DHT (Stanolone) | 6.2 A | 100mg/ml | 122.3mg/ml | +22.3% | 97.82% | fsg1ny | Lab A | Public |
| 12 Dec 2025 | Hyaluronic acid | 8.5 A | 2mg | 2.4mg | +18.7% | 95.68% | ulyn50 | Lab E | Public |
| 12 Dec 2025 | Salbutamol | 8.4 A | 20mg | 21.5mg | +7.3% | 99.45% | 1h2czd | Lab F | Public |
| 12 Dec 2025 | Testagen | 5.7 B | 5mg | 5.4mg | +7.9% | 97.33% | 717vxq | Lab A | Public |
| 12 Dec 2025 | Tren Hex | 8.5 A | 250mg/ml | 225.4mg/ml | -9.9% | 97.86% | wttq8u | Lab E | Public |
| 5 Dec 2025 | EPO | 7.7 A | 20mg | 20.7mg | +3.5% | 98.56% | 7jv7ln | Lab C | Community |
| 23 Nov 2025 | Aromasin (Exemestane) | 5.6 B | 20mg | 20.5mg | +2.6% | 99.54% | 4xxoqc | Lab F | Public |
| 23 Nov 2025 | Orforglipron | 7.0 A | 50mg | 48.1mg | -3.9% | 96.47% | bodqb9 | Lab A | Community |
| 23 Nov 2025 | Vitamin B12 10mg/ml | 7.4 A | 250mg/ml | 222.2mg/ml | -11.1% | 98.41% | ibjdia | Lab G | Public |
| 17 Nov 2025 | Pancragen | 4.4 C | 5mg | 4.4mg | -11.1% | 97.29% | 807m1t | Lab C | Public |
| 17 Nov 2025 | Testagen | 6.2 A | 10mg | 8.6mg | -14.1% | 97.29% | v1gmpa | Lab F | Public |
| 14 Nov 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 7.2 A | 50mg | 59.8mg | +19.6% | 97.09% | vhl59t | Lab D | Public |
| 14 Nov 2025 | Epithalon | 5.9 B | 10mg | 9.6mg | -3.9% | 95.55% | 2atwal | Lab F | Public |
| 14 Nov 2025 | Pancragen | 6.5 A | 2mg | 1.9mg | -4.9% | 97.47% | 8ebxh2 | Lab D | Public |
| 14 Nov 2025 | Salbutamol | 8.5 A | 25mg | 24.8mg | -0.6% | 99.61% | t6fsvx | Lab B | Community |
| 5 Nov 2025 | AOD9604 | 8.0 A | 20mg | 19.8mg | -1.0% | 99.50% | vmcr0o | Lab D | Community |
| 5 Nov 2025 | Super Shred | 5.2 B | 250mg/ml | 213.1mg/ml | -14.7% | 99.34% | gprt1a | Lab D | Community |
| 4 Nov 2025 | Dianabol | 10.0 A | 100mg | 122.3mg | +22.3% | 96.32% | yt02lb | Lab G | Public |
| 17 Oct 2025 | Dianabol | 8.4 A | 100mg | 115.6mg | +15.6% | 99.18% | nhqimo | Lab G | Public |
— END OF EVIDENCE LOG —